Cuéllar-Barboza, Alfredo B.
McElroy, Susan L.
Veldic, Marin
Singh, Balwinder
Kung, Simon
Romo-Nava, Francisco
Nunez, Nicolas A.
Cabello-Arreola, Alejandra
Coombes, Brandon J.
Prieto, Miguel
Betcher, Hannah K.
Moore, Katherine M.
Winham, Stacey J.
Biernacka, Joanna M.
Frye, Mark A.
Article History
Received: 15 August 2019
Accepted: 7 March 2020
First Online: 4 July 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AB Cuellar-Barboza reports no financial relationships with commercial interests. SL McElroy has been a consultant to or member of the scientific advisory boards of Allergan, Avanir, Bracket, F. Hoffmann-La Roche Ltd., Mitsubishi Tanabe Pharma America, Myriad, Opiant, Shire, and Sunovion. She has been a principal or co-investigator on studies sponsored by Allergan, Avanir, Azevan, Brainsway, Marriott Foundation, Medibio, Myriad, Neurocrine, Novo Nordisk, Shire, and Sunovion. She is also an inventor on United States Patent No. 6,323,236 B2, Use of Sulfamate Derivatives for Treating Impulse Control Disorders, and along with the patent’s assignee, University of Cincinnati, Cincinnati, Ohio, has received payments from Johnson & Johnson, which has exclusive rights under the patent. M Veldic reports no financial relationships with commercial interests. B Singh received research time support from Medibio, unrelated to the current study. S Kung reports no financial relationships with commercial interests. F Romo-Nava reports no financial relationships with commercial interests. N Nuñez reports no financial relationships with commercial interests. A Cabello-Arreola reports no financial relationships with commercial interests. B Coombes reports no financial relationships with commercial interests. M Prieto reports no financial relationships with commercial interests. HK Betcher reports no financial relationships with commercial interests. KM Moore reports no financial relationships with commercial interests. SJ Winham reports no financial relationships with commercial interests. JM Biernacka reports no financial relationships with commercial interests. MA Frye reports Grant Support from Assurex Health, Mayo Foundation, Medibio. Consultant (Mayo) - Actify Neurotherapies, Allergan, Intra-Cellular Therapies, Inc., Janssen, Myriad, Neuralstem Inc.,Takeda, Teva Pharmaceuticals. He reports CME/Travel/Honoraria from the American Physician Institute, CME Outfitters, Global Academy for Medical Education. Mayo Clinic has a financial interest in AssureRX and OneOme and the technology referenced in this publication.